tetradecanoylphorbol acetate has been researched along with Fatigue Syndrome, Chronic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bosmans, E; Maes, M; Mihaylova, I | 1 |
Blauw, B; de Kloet, R; Graffelman, W; Haspels, I; Lentjes, E; Nagelkerken, L; Visser, J | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and Fatigue Syndrome, Chronic
Article | Year |
---|---|
Not in the mind of neurasthenic lazybones but in the cell nucleus: patients with chronic fatigue syndrome have increased production of nuclear factor kappa beta.
Topics: Adult; Case-Control Studies; Cell Nucleus; Fatigue Syndrome, Chronic; Female; Humans; Inflammation; Lymphocytes; Male; Middle Aged; Neurasthenia; NF-kappa B; Oxidative Stress; Severity of Illness Index; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2007 |
Increased sensitivity to glucocorticoids in peripheral blood mononuclear cells of chronic fatigue syndrome patients, without evidence for altered density or affinity of glucocorticoid receptors.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Cells, Cultured; Cytokines; Dexamethasone; Fatigue Syndrome, Chronic; Female; Humans; Hydrocortisone; Leukocytes, Mononuclear; Male; Middle Aged; Receptors, Glucocorticoid; Tetradecanoylphorbol Acetate | 2001 |